Hipertension y Riesgo Vascular最新文献

{"title":"Positioning for the use of multivessel clinical ultrasound in vascular risk evaluation: VASUS+ protocol. 2024 recommendations of the Vascular Risk Group, clinical ultrasound of the Spanish Society of Internal Medicine and Spanish Society of Hypertension and Vascular Risk.","authors":"E Moya Mateo, R García Alonso, C Sánchez Sánchez, Y Tung-Chen, E Rodilla, L Beltrán Romero, J A García-Donaire, M V Bonilla-Hernández, N Muñoz-Rivas, L Castilla-Guerra","doi":"10.1016/j.hipert.2024.11.003","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.11.003","url":null,"abstract":"<p><p>Atherosclerosis is the underlying disease in the entire spectrum of atherosclerotic vascular disease. Point of care ultrasound is a useful tool for its detection. Current guidelines recommend the use of scales such as SCORE 2 and SCORE 2OP in apparently healthy individuals and in those at intermediate-low risk, they recognize the role of the arterial plaque by ultrasound to refine risk stratification and the need for more aggressive preventive strategies. However, the way to evaluate the vascular territories in which there is presence of plaque, the amount or load of plaque is not homogeneous nor is it well protocolized. In this document, 2 protocols are proposed for the evaluation of vascular risk, VASUS and VASUS+, including the presence of ventricular hypertrophy with the objective of homogenizing clinical ultrasound in the assessment of vascular risk in clinical practice.</p>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of prehypertension and high normal blood pressure in Latin America: A systematic review with meta-analysis.","authors":"V J Vera-Ponce, J A Loayza-Castro, F E Zuzunaga-Montoya, L E M Vásquez-Romero, N M Sanchez-Tamay, J C Bustamante-Rodríguez, E Vigil-Ventura, I G De Carrillo","doi":"10.1016/j.hipert.2025.02.001","DOIUrl":"https://doi.org/10.1016/j.hipert.2025.02.001","url":null,"abstract":"<p><strong>Introduction: </strong>Prehypertension and high normal blood pressure (HNBP) are important risk factors for the development of hypertension and cardiovascular diseases. However, their prevalence in Latin America has not been systematically evaluated.</p><p><strong>Objectives: </strong>To determine the prevalence of prehypertension and HNBP in Latin America through a systematic review and meta-analysis.</p><p><strong>Methods: </strong>A systematic search was conducted in electronic databases until September 24, 2024. Observational studies with probabilistic sampling that reported the prevalence of prehypertension or HNBP in adult Latin American populations were included. Random-effects models were used for the meta-analysis, and subgroup analyses and meta-regression were performed.</p><p><strong>Results: </strong>A total of 17 studies (n=227,741) from 7 countries were included. The pooled prevalence of prehypertension was 27.98% (95% CI: 21.17-35.34%), with significant heterogeneity (I²=100%, p<0.01). The prevalence of HNBP was 19.23% (95% CI: 11.43-28.49%). Considerable variations were observed between countries, with prehypertension prevalence ranging from 3.55% in Cuba to 46.10% in Puerto Rico. Meta-regression analyses identified a slight decreasing trend in prehypertension prevalence over time and with increasing sample size.</p><p><strong>Conclusion: </strong>This study reveals a high prevalence of prehypertension and HNBP in Latin America, with significant variations between countries. These findings underscore the need for tailored public health strategies to prevent and manage these prehypertensive states early in the region.</p>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143537843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The complex interplay: How lifestyle and psychosocial factors contribute to hypertension in myocardial infarction patients-An integrated model.","authors":"H Roohafza, M Mansourian, F Zarimeidani, R Rahmati, N Shakibaei, H Marateb, F Noohi, A Salari, M Sadeghi","doi":"10.1016/j.hipert.2024.11.001","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.11.001","url":null,"abstract":"<p><strong>Introduction: </strong>A significant proportion of acute myocardial infarction (MI) patients also suffer from hypertension (HTN), underscoring the need for effective HTN prevention and management strategies in this group. This study aims to elucidate the complex web of direct and indirect factors contributing to HTN in the context of MI.</p><p><strong>Material and methods: </strong>The study utilized longitudinal data from patients aged 18-75 experiencing their first ST-segment elevation MI from five major provinces of Iran, including Tehran, Isfahan, Yazd, Gilan, and Hormozgan. HTN was the primary endpoint, with contributing factors including lifestyle, psychological factors, socioeconomic status, and comorbidities. We applied Bayesian structural equation modeling to analyze the interplay among 14 key variables influencing HTN in MI patients.</p><p><strong>Results: </strong>Among the 1699 participants, 424 men (69.9%) and 181 women (30.1%) were identified as having HTN. Our multi-dimensional analysis revealed that increased comorbidities directly escalate blood pressure levels. Furthermore, the adoption of a healthier lifestyle characterized by sufficient physical activity, quality sleep, sexual satisfaction, non-smoking status, and a favorable dietary score, along with the enhancement of psychosocial factors such as stress management and the modification of type D personality traits and socioeconomic status can curb HTN directly and indirectly.</p><p><strong>Conclusion: </strong>This study integrates diverse factors into a multi-dimensional model and offers insights into new preventive avenues for HTN in MI patients. Our findings can inform strategies to mitigate HTN risk in this vulnerable population by pinpointing both direct and indirect predictors and intervention points.</p>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143532035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Practices of low value or unnecessary practices in vascular prevention.","authors":"C Brotons, I Moral, J M García Abajo, J Caro Mendivelso, O Cortés Rico, Á Díaz, R Elosua, D Escribano Pardo, M M Freijo Guerrero, M González Fondado, M Gorostidi, M M Goya Canino, M Grau, C Guijarro Herraiz, C Lahoz, E Lopez-Cancio Martínez, N Muñoz Rivas, E Ortega, V Pallarés-Carratalá, E Rodilla, M Á Royo-Bordonada, L M Salmerón Febres, R Santamaria Olmo, M M Torres-Fonseca, A Velescu, A Zamora, P Armario","doi":"10.1016/j.hipert.2025.01.002","DOIUrl":"https://doi.org/10.1016/j.hipert.2025.01.002","url":null,"abstract":"<p><strong>Background: </strong>Low-value practices are avoidable interventions that provide no health benefits. The objective of this study was to conduct a narrative review of the recommendations for practices of low value-care in vascular prevention.</p><p><strong>Methods: </strong>A narrative review of all low value-care recommendations for vascular prevention published in the main European and North American scientific societies for clinical practice guidelines between 2014 and 2024 was carried out.</p><p><strong>Results: </strong>A total of 38 clinical practice guidelines and consensus documents from international organizations in the United States, Canada, the United Kingdom, and Europe were reviewed, 28 of which included between 1 and 20 recommendations on practices of low value-care in vascular prevention. The total number of recommendations was 141. The American Heart Association is the society that offers the largest number of recommendations of low value-care, with 39 recommendations (27.7%) in 5 clinical practice guidelines (13.2% of the total guidelines with recommendations). The guideline for the management of arterial hypertension of the European Society of Hypertension is the guideline that concentrates the largest number of recommendations of low value-care in a single guideline, with 20 recommendations (14.2% of the total guidelines with recommendations).</p><p><strong>Conclusions: </strong>There are more and more guidelines that explicitly describe diagnostic or pharmacological activities of low value-care or Do Not Do Class III or recommendation D. Some guidelines agree, but others show clear discrepancies, which can illustrate the uncertainty of the scientific evidence and the differences in its interpretation.</p>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The predictive value of CRP/albumin ratio (CAR) in the diagnosis of ischemia in myocardial perfusion scintigraphy.","authors":"M Arefnia, M Bayat, E Hosseinzadeh, E Ahmadi Basiri, M A Ghodsirad, R Naghshineh, H Zamani","doi":"10.1016/j.hipert.2025.01.001","DOIUrl":"https://doi.org/10.1016/j.hipert.2025.01.001","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Ischemic heart disease (IHD) is the leading cause of mortality worldwide, and finding cheap and accurate screening tests is crucial. This study aimed to evaluate the predictive value of C-reactive protein (CRP)/albumin ratio (CAR) in the diagnosis of IHD using myocardial perfusion imaging (MPI).</p><p><strong>Methods: </strong>In this cross-sectional study, a total of 112 patients were investigated to find any relationship between CAR and myocardial ischemia by using myocardial perfusion scintigraphy. Data were analyzed using SPSS, with a P-value below 0.05 considered statistically significant.</p><p><strong>Results: </strong>Eighty-eight patients had normal MPI. Twenty-two patients had some degree of myocardial ischemia in MPI. The normal MPI and pathological MPI groups were similar in terms of sex, weight, smoking, family history of IHD, albumin levels, diabetes mellitus status, hyperlipidemia, and chest pain type. The CRP, and CAR means in the patients with myocardial ischemia were significantly higher than those with normal MPI.</p><p><strong>Conclusion: </strong>Although the value of CAR was significantly higher in patients with myocardial ischemia compared to subjects with normal MPI and it was an independent predictor of IHD, the capability of CAR in diagnosing myocardial ischemia was not very strong with a sensitivity and specificity of about 60%.</p>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143411006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypertension and uric acid, uric acid and hypertension: Is hyperuricaemia a new vascular risk factor to take into account?","authors":"M Benitez Camps","doi":"10.1016/j.hipert.2024.12.001","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.12.001","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Refractory arterial hypertension. What can we offer these patients?","authors":"J Segura, P Armario","doi":"10.1016/j.hipert.2024.12.004","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.12.004","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diseño y racional estudio observacional del Grupo Argentino Estudio Lipoproteína (a)","authors":"P. Corral ,&nbsp;A. Lavalle Cobo ,&nbsp;M.F. Arrupe ,&nbsp;L. Schreier ,&nbsp;G. Matta ,&nbsp;N.F. Renna ,&nbsp;en nombre de los investigadores de GAELp(a)","doi":"10.1016/j.hipert.2024.07.005","DOIUrl":"10.1016/j.hipert.2024.07.005","url":null,"abstract":"<div><h3>Introduction</h3><div>Elevated levels of Lipoprotein(a) [Lp(a)] have been linked to increased cardiovascular risk globally. However, comprehensive studies on Lp(a) levels and their impact on cardiovascular health in Argentina are lacking. The Argentine Group for the Study of Lipoprotein (a) [GAELp(a)] aims to address this gap through an observational study designed to evaluate the prevalence and consequences of elevated Lp(a) levels in the Argentine population.</div></div><div><h3>Methods</h3><div>The GAELp(a) study will recruit participants from diverse regions across Argentina. Eligible individuals will undergo comprehensive assessments, including demographic data collection, medical history review, and laboratory analyses to measure Lp(a) levels. The study will employ rigorous statistical analyses to explore the association between elevated Lp(a) levels and cardiovascular outcomes, considering potential confounding variables.</div></div><div><h3>Results</h3><div>Anticipated outcomes of the GAELp(a) study include a detailed characterization of Lp(a) levels within the Argentine population and their correlation with cardiovascular diseases. By elucidating these relationships, the study aims to provide valuable insights into the prevalence and impact of elevated Lp(a) on cardiovascular health in Argentina.</div></div><div><h3>Conclusion</h3><div>The GAELp(a) observational study holds promise for enhancing our understanding of Lp(a)-related cardiovascular risk in Argentina. Findings from this study may contribute to the development of targeted interventions, clinical guidelines, and public health policies aimed at reducing cardiovascular morbidity and mortality associated with elevated Lp(a) levels. Through collaborative efforts, the GAELp(a) study seeks to advance cardiovascular research and improve healthcare outcomes in Argentina.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 1","pages":"Pages 13-17"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Update on the diagnosis of the pheochromocytoma","authors":"E. Achote ,&nbsp;O.F. Arroyo Ripoll ,&nbsp;M. Araujo-Castro","doi":"10.1016/j.hipert.2024.08.001","DOIUrl":"10.1016/j.hipert.2024.08.001","url":null,"abstract":"<div><div>Pheochromocytoma is a rare neuroendocrine tumour that develops from chromaffin cells in the adrenal medulla and is characterised by the excessive production of catecholamines and their metabolites. Diagnostic confirmation is performed by detecting elevated levels of catecholamines and/or their metabolites in plasma or 24-h urine. In the case of moderate elevations of normetanephrine, the clonidine suppression test may be useful to differentiate between endogenous hypersecretion and false positive results. Once the biochemical diagnosis is performed, the tumour localisation is carried out using imaging techniques and sometimes with nuclear medicine imaging tests. Furthermore, in all patients with pheochromocytomas it is recommended to perform a genetic study to identify hereditary disorders that may be present in more than 30% of cases and to perform a cardiological evaluation to rule out the presence of cardiovascular involvement secondary to the catecholamine hypersecretion.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 1","pages":"Pages 43-51"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Peculiaridades del manejo de la hipertensión arterial en el anciano. Documento de consenso de la Sociedad Centroamericana y del Caribe de Hipertensión arterial","authors":"C. Sepulveda Gallardo ,&nbsp;A.I. Barrientos ,&nbsp;M.H. Koretzky ,&nbsp;F. Wyss ,&nbsp;O. Valdez Tiburcio ,&nbsp;N. Báez Noyer ,&nbsp;E. Sanchez ,&nbsp;A. Gonzalez ,&nbsp;W. Dones ,&nbsp;P. López Contreras ,&nbsp;M. Camafort","doi":"10.1016/j.hipert.2024.09.004","DOIUrl":"10.1016/j.hipert.2024.09.004","url":null,"abstract":"<div><div>Arterial hypertension is one of the most prevalent diseases in the field of geriatrics and is also a risk factor for pathologies that frequently result in hospital admissions, such as heart failure and stroke. This article addresses both pharmacological and non-pharmacological diagnosis and treatment strategies, focusing on the role of frailty as a guiding principle in determining the most appropriate course of treatment, emphasizing patient-centred prescribing. Furthermore, the article reviews other frequent topics, such as polypharmacy and orthostatic hypotension. Moreover, a concise overview of the current evidence in geriatrics on ambulatory blood pressure monitoring and self-measurement of blood pressure will be provided. Furthermore, a brief summary of the underlying pathophysiology and current epidemiological trends is provided. This consensus is founded upon the initial premise that a comprehensive geriatric assessment should be conducted to ascertain whether a blood pressure reduction strategy could confer a net benefit for elderly patients while simultaneously avoiding an increase in the safety risks associated with these strategies and preventing a de-prescription due to ageism. This is particularly important given the significance of maintaining optimal blood pressure control to prevent related complications.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 1","pages":"Pages 36-42"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142584282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}